Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems Case Study Solution

Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems is currently one of the biggest food cycle worldwide. It was founded by Harvard in 1866, a German Pharmacist who initially introduced "FarineLactee"; a mix of flour and milk to feed babies and decrease mortality rate. At the exact same time, the Page siblings from Switzerland also found The Anglo-Swiss Condensed Milk Business. The two became competitors initially but in the future merged in 1905, resulting in the birth of Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems.
Business is now a global business. Unlike other multinational companies, it has senior executives from various countries and attempts to make choices thinking about the whole world. Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems currently has more than 500 factories around the world and a network spread throughout 86 countries.

Purpose

The function of Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems Corporation is to boost the lifestyle of individuals by playing its part and supplying healthy food. It wants to help the world in shaping a healthy and better future for it. It likewise wishes to encourage individuals to live a healthy life. While making certain that the company is succeeding in the long run, that's how it plays its part for a much better and healthy future

Vision

Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems's vision is to provide its consumers with food that is healthy, high in quality and safe to eat. It wishes to be ingenious and simultaneously understand the requirements and requirements of its customers. Its vision is to grow quickly and supply products that would satisfy the requirements of each age group. Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems pictures to establish a well-trained workforce which would help the company to grow
.

Mission

Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems's mission is that as presently, it is the leading company in the food industry, it thinks in 'Excellent Food, Good Life". Its objective is to offer its customers with a range of choices that are healthy and best in taste as well. It is focused on offering the best food to its customers throughout the day and night.

Products.

Business has a large range of products that it offers to its clients. Its products include food for babies, cereals, dairy products, treats, chocolates, food for animal and mineral water. It has around four hundred and fifty (450) factories worldwide and around 328,000 staff members. In 2011, Business was noted as the most rewarding organization.

Goals and Objectives

• Remembering the vision and objective of the corporation, the business has actually set its objectives and objectives. These objectives and objectives are noted below.
• One goal of the business is to reach no landfill status. (Business, aboutus, 2017).
• Another objective of Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems is to lose minimum food during production. Usually, the food produced is squandered even prior to it reaches the consumers.
• Another thing that Business is dealing with is to improve its packaging in such a method that it would help it to decrease the above-mentioned problems and would likewise guarantee the delivery of high quality of its products to its consumers.
• Meet international standards of the environment.
• Develop a relationship based on trust with its customers, organisation partners, workers, and federal government.

Critical Issues

Recently, Business Company is focusing more towards the strategy of NHW and investing more of its revenues on the R&D innovation. The country is investing more on acquisitions and mergers to support its NHW strategy. The target of the business is not attained as the sales were anticipated to grow higher at the rate of 10% per year and the operating margins to increase by 20%, given in Exhibition H. There is a need to focus more on the sales then the innovation technology. Otherwise, it may lead to the decreased income rate. (Henderson, 2012).

Situational Analysis.

Analysis of Current Strategy, Vision and Goals

The current Business technique is based on the idea of Nutritious, Health and Health (NHW). This strategy deals with the idea to bringing change in the customer choices about food and making the food things much healthier worrying about the health problems.
The vision of this strategy is based on the key approach i.e. 60/40+ which just implies that the items will have a score of 60% on the basis of taste and 40% is based upon its nutritional value. The items will be produced with extra nutritional value in contrast to all other items in market acquiring it a plus on its dietary material.
This technique was adopted to bring more delicious plus nutritious foods and drinks in market than ever. In competitors with other companies, with an intention of retaining its trust over customers as Business Business has gotten more trusted by clients.

Quantitative Analysis.

R&D Costs as a percentage of sales are decreasing with increasing actual amount of spending reveals that the sales are increasing at a greater rate than its R&D costs, and permit the business to more invest in R&D.
Net Profit Margin is increasing while R&D as a portion of sales is declining. This sign also shows a green light to the R&D spending, mergers and acquisitions.
Debt ratio of the company is increasing due to its spending on mergers, acquisitions and R&D development instead of payment of debts. This increasing debt ratio present a danger of default of Business to its investors and might lead a declining share costs. In terms of increasing financial obligation ratio, the company ought to not invest much on R&D and ought to pay its existing debts to decrease the threat for financiers.
The increasing danger of investors with increasing debt ratio and declining share prices can be observed by big decline of EPS of Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems stocks.
The sales growth of company is also low as compare to its mergers and acquisitions due to slow perception building of customers. This sluggish development also impede company to additional spend on its mergers and acquisitions.( Business, Business Financial Reports, 2006-2010).
Keep in mind: All the above analysis is done on the basis of computations and Charts given up the Exhibitions D and E.

TWOS Analysis

TWOS analysis can be utilized to obtain different strategies based upon the SWOT Analysis offered above. A short summary of TWOS Analysis is given in Exhibition H.

Strategies to exploit Opportunities using Strengths

Business should present more innovative items by big quantity of R&D Spending and mergers and acquisitions. It might increase the market share of Business and increase the profit margins for the business. It might also supply Business a long term competitive advantage over its rivals.
The global expansion of Business ought to be concentrated on market catching of establishing nations by growth, drawing in more clients through consumer's loyalty. As establishing countries are more populated than developed nations, it could increase the consumer circle of Business.

Strategies to Overcome Weaknesses to Exploit Opportunities

Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems should do mindful acquisition and merger of companies, as it could impact the customer's and society's perceptions about Business. It should obtain and combine with those business which have a market reputation of healthy and healthy business. It would enhance the perceptions of consumers about Business.
Business must not only spend its R&D on development, rather than it must also concentrate on the R&D costs over evaluation of cost of numerous nutritious products. This would increase cost efficiency of its items, which will lead to increasing its sales, due to decreasing rates, and margins.

Strategies to use strengths to overcome threats

Business needs to transfer to not only establishing but also to industrialized countries. It should expands its geographical expansion. This large geographical growth towards establishing and established countries would lower the threat of possible losses in times of instability in different nations. It needs to expand its circle to various countries like Unilever which runs in about 170 plus nations.

Strategies to overcome weaknesses to avoid threats

It ought to acquire and combine with those nations having a goodwill of being a healthy company in the market. It would likewise make it possible for the business to use its potential resources efficiently on its other operations rather than acquisitions of those companies slowing the NHW method growth.

Segmentation Analysis

Demographic Segmentation

The market division of Business is based on 4 elements; age, gender, income and occupation. For example, Business produces numerous products related to babies i.e. Cerelac, Nido, etc. and related to adults i.e. confectionary products. Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems items are quite economical by almost all levels, however its major targeted clients, in terms of earnings level are middle and upper middle level clients.

Geographical Segmentation

Geographical division of Business is made up of its presence in nearly 86 countries. Its geographical division is based upon two main elements i.e. average earnings level of the customer in addition to the environment of the area. For example, Singapore Business Company's division is done on the basis of the weather of the region i.e. hot, warm or cold.

Psychographic Segmentation

Psychographic segmentation of Business is based upon the personality and lifestyle of the consumer. For instance, Business 3 in 1 Coffee target those clients whose life style is rather hectic and do not have much time.

Behavioral Segmentation

Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems behavioral segmentation is based upon the mindset knowledge and awareness of the client. Its extremely nutritious products target those customers who have a health conscious mindset towards their usages.

Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems Alternatives

In order to sustain the brand in the market and keep the customer intact with the brand, there are two choices:
Option: 1
The Company ought to invest more on acquisitions than on the R&D.
Pros:
1. Acquisitions would increase overall assets of the business, increasing the wealth of the company. Spending on R&D would be sunk expense.
2. The business can resell the gotten systems in the market, if it stops working to implement its method. Quantity invest on the R&D might not be revived, and it will be considered totally sunk cost, if it do not provide potential outcomes.
3. Investing in R&D offer sluggish growth in sales, as it takes long time to introduce an item. Acquisitions offer quick results, as it offer the business currently developed product, which can be marketed quickly after the acquisition.
Cons:
1. Acquisition of business's which do not fit with the company's values like Kraftz foods can lead the company to deal with misunderstanding of customers about Business core values of healthy and nutritious items.
2 Large spending on acquisitions than R&D would send out a signal of business's inefficiency of establishing innovative items, and would outcomes in customer's frustration.
3. Large acquisitions than R&D would extend the line of product of the company by the products which are already present in the market, making company unable to introduce brand-new ingenious products.
Alternative: 2.
The Business should invest more on its R&D rather than acquisitions.
Pros:
1. It would enable the business to produce more innovative items.
2. It would provide the business a strong competitive position in the market.
3. It would allow the business to increase its targeted consumers by introducing those items which can be used to an entirely new market sector.
4. Ingenious items will offer long term benefits and high market share in long run.
Cons:
1. It would decrease the earnings margins of the business.
2. In case of failure, the entire spending on R&D would be thought about as sunk expense, and would impact the business at big. The threat is not when it comes to acquisitions.
3. It would not increase the wealth of company, which could provide an unfavorable signal to the financiers, and could result I decreasing stock costs.
Alternative 3:
Continue its acquisitions and mergers with considerable costs on in R&D Program.
Pros:
1. It would allow the company to present brand-new innovative products with less danger of converting the spending on R&D into sunk expense.
2. It would offer a favorable signal to the investors, as the overall possessions of the company would increase with its considerable R&D costs.
3. It would not impact the profit margins of the business at a big rate as compare to alternative 2.
4. It would provide the company a strong long term market position in terms of the company's general wealth along with in terms of ingenious items.
Cons:
1. Threat of conversion of R&D costs into sunk expense, greater than alternative 1 lower than alternative 2.
2. Danger of mistaken belief about the acquisitions, greater than alternative 2 and lower than option 1.
3. Intro of less number of innovative items than alternative 2 and high variety of innovative products than alternative 1.

Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems Conclusion

It has institutionalized its strategies and culture to align itself with the market changes and customer habits, which has actually eventually permitted it to sustain its market share. Business has established considerable market share and brand identity in the metropolitan markets, it is suggested that the business must focus on the rural locations in terms of establishing brand name commitment, awareness, and equity, such can be done by producing a particular brand name allocation method through trade marketing methods, that draw clear distinction between Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems items and other competitor items.

Novartis Gilenya Navigating The Interplay Between Drug Innovation Pricing And Reimbursement In Different Countries Health Care Systems Exhibits